74 related articles for article (PubMed ID: 2486910)
1. Flow-cytometric determination of intracellular pH, esterase activity and cell volume in human leukemic cell lines following in vitro incubation with cytostatic drugs.
Neubauer A; Valet G; Huhn D
Anal Cell Pathol; 1989 Dec; 2(1):49-58. PubMed ID: 2486910
[TBL] [Abstract][Full Text] [Related]
2. Cytostatic drug testing in human leukemias by means of multiparametric flow cytometry.
Neubauer A; Sauer H; Valet G
Blut; 1987 Nov; 55(5):433-45. PubMed ID: 3676521
[TBL] [Abstract][Full Text] [Related]
3. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
[TBL] [Abstract][Full Text] [Related]
4. Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities.
Majlessipour F; Kwock R; Martin-Aragon S; Weinberg KI; Avramis VI
Anticancer Res; 2001; 21(1A):11-22. PubMed ID: 11299723
[TBL] [Abstract][Full Text] [Related]
5. Intracellular pH, esterase activity, and DNA measurements of human lung carcinomas by flow cytometry.
Liewald F; Demmel N; Wirsching R; Kahle H; Valet G
Cytometry; 1990; 11(3):341-8. PubMed ID: 2340771
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
8. Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin content.
Ross DD; Thompson BW; Ordóñez JV; Joneckis CC
Cytometry; 1989 Mar; 10(2):185-91. PubMed ID: 2714107
[TBL] [Abstract][Full Text] [Related]
9. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
10. Drug sensitivity assay for leukaemic cells by flow cytometry.
Gupta M; Naik S; Pandey CM; Dabadghao S
Indian J Med Res; 2002 Jun; 115():260-4. PubMed ID: 12440199
[TBL] [Abstract][Full Text] [Related]
11. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
Catchpoole DR; Stewart BW
Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
[TBL] [Abstract][Full Text] [Related]
12. Drug testing in established cell lines by flow cytometric vitality measurements versus clonogenic assay.
Ellwart JW; Kremer JP; Dörmer P
Cancer Res; 1988 Oct; 48(20):5722-5. PubMed ID: 3167831
[TBL] [Abstract][Full Text] [Related]
13. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system.
Kishi S; Goto N; Nakamura T; Ueda T
Cancer Res; 1999 Jun; 59(11):2629-34. PubMed ID: 10363985
[TBL] [Abstract][Full Text] [Related]
15. Intracellular pH measurements using flow cytometry with 1,4-diacetoxy-2,3-dicyanobenzene.
Cook JA; Fox MH
Cytometry; 1988 Sep; 9(5):441-7. PubMed ID: 3180945
[TBL] [Abstract][Full Text] [Related]
16. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
17. Automated fluorescent analysis for drug-induced cytotoxicity assays.
Funa K; Dawson N; Jewett PB; Agren H; Ruckdeschel JC; Bunn PA; Gazdar AF
Cancer Treat Rep; 1986 Oct; 70(10):1147-51. PubMed ID: 3019545
[TBL] [Abstract][Full Text] [Related]
18. In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia.
Hubeek I; Peters GJ; Broekhuizen R; Zwaan CM; Kaaijk P; van Wering ES; Gibson BE; Creutzig U; Janka-Schaub GE; den Boer ML; Pieters R; Kaspers GJ
Haematologica; 2006 Jan; 91(1):17-23. PubMed ID: 16434366
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelium: target or victim of cytostatic therapy?
Romanov YA; Chervontseva AM; Savchenko VG; Smirnov VN
Can J Physiol Pharmacol; 2007; 85(3-4):396-403. PubMed ID: 17612648
[TBL] [Abstract][Full Text] [Related]
20. Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysis.
Nakeff A; KuKuruga MA; Media JE; Valeriote F; Edelstein MB
J Exp Ther Oncol; 1996 Nov; 1(6):361-7. PubMed ID: 9414426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
